Allograft nephrectomy: a systematic review of immunological consequences and management of immunosuppressants
Transplant International · 03.07.2026 · 39
DOI: 10.3389/ti.2026.16661 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Transplant International, online erschienen am 03.07.2026. Verfasst von Arnaud Del Bello und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology and Organ Transplant Department, CHU de Toulouse, Toulouse, France. Hauptthemen laut MEDLINE: Kidney Transplantation, Immunosuppressive Agents, Nephrectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Allograft nephrectomy (AN) is a serious complication of kidney transplantation. Beyond surgical morbidity, AN has important immunological implications. We performed a systematic review to synthesize current evidence on the immunological impact of AN and post-allograft failure immunosuppressive strategies. A systematic review was conducted according to PRISMA guidelines. PubMed/Medline® was searched for studies published from 01/2000 to 03/2026 on transplantectomy indications and surgical techniques. Eligible designs included meta-analyses, randomized trials, and prospective or retrospective studies evaluating the immunological impact of AN and/or immunosuppression management before, during, or after graft removal in adult or pediatric kidney transplant recipients returning to dialysis. Consistent evidence indicates that immunosuppression withdrawal is the principal driver of allosensitization after graft failure. Multiple studies demonstrated marked increases in anti-HLA antibodies following the cessation of immunosuppression, regardless of nephrectomy status. When AN was performed under maintained immunosuppression, its independent effect on sensitization and retransplant outcomes appeared limited. Meta-analyses showed comparable survival after retransplantation, although higher PRA levels, delayed graft function, and acute rejection were more frequent in patients with prior nephrectomy. Allosensitization after graft failure is primarily driven by immunosuppression withdrawal/reduction rather than AN itself. Individualized immunosuppressive management balancing immunological and infectious risks is essential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephrology and Organ Transplant Department, CHU de Toulouse, Toulouse, France.
- Department of Urology, CHU de Rennes, Rennes, France.
- Department of Methodology, Association Française d'Urologie, Paris, France.
- Department of Urology, CHU de Toulouse, Toulouse, France.
- Department of Urology, CHU de Besançon, Besançon, France.
- Department of Urology, CHU d'Amiens, Amiens, France.
Zitieren
APA
Del Bello, A., Goujon, A., Kassab, D., Prudhomme, T., Frontczak, A., & Culty, T. (2026). Allograft nephrectomy: a systematic review of immunological consequences and management of immunosuppressants. Transplant International, 39. https://doi.org/10.3389/ti.2026.16661
Vancouver
Del Bello A, Goujon A, Kassab D, Prudhomme T, Frontczak A, Culty T. Allograft nephrectomy: a systematic review of immunological consequences and management of immunosuppressants. Transplant International. 2026;39. doi:10.3389/ti.2026.16661
BibTeX
@article{DelBello2026,
author = {Del Bello, Arnaud and Goujon, Anna and Kassab, Diana and Prudhomme, Thomas and Frontczak, Alexandre and Culty, Thibault},
title = {Allograft nephrectomy: a systematic review of immunological consequences and management of immunosuppressants},
journal = {Transplant International},
year = {2026},
volume = {39},
doi = {10.3389/ti.2026.16661}
}
EUVIMED